BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kunze FA, Bauer M, Komuczki J, Lanzinger M, Gunasekera K, Hopp AK, Lehmann M, Becher B, Müller A, Hottiger MO. ARTD1 in Myeloid Cells Controls the IL-12/18-IFN-γ Axis in a Model of Sterile Sepsis, Chronic Bacterial Infection, and Cancer. J Immunol 2019;202:1406-16. [PMID: 30674576 DOI: 10.4049/jimmunol.1801107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Miettinen M, Vedantham M, Pulliainen AT. Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections. Microbes and Infection 2019;21:423-31. [DOI: 10.1016/j.micinf.2019.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang C, Xiao J, Nowak K, Gunasekera K, Alippe Y, Speckman S, Yang T, Kress D, Abu-Amer Y, Hottiger MO, Mbalaviele G. PARP1 Hinders Histone H2B Occupancy at the NFATc1 Promoter to Restrain Osteoclast Differentiation. J Bone Miner Res 2020;35:776-88. [PMID: 31793068 DOI: 10.1002/jbmr.3927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Mahapatro M, Erkert L, Becker C. Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut. Cells 2021;10:111. [PMID: 33435303 DOI: 10.3390/cells10010111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Wang C, Mbalaviele G. Role of APD-Ribosylation in Bone Health and Disease. Cells 2019;8:E1201. [PMID: 31590342 DOI: 10.3390/cells8101201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Arruri VK, Gundu C, Khan I, Khatri DK, Singh SB. PARP overactivation in neurological disorders. Mol Biol Rep 2021;48:2833-41. [PMID: 33768369 DOI: 10.1007/s11033-021-06285-1] [Reference Citation Analysis]
6 Yélamos J, Moreno-Lama L, Jimeno J, Ali SO. Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies. Cancers (Basel) 2020;12:E392. [PMID: 32046278 DOI: 10.3390/cancers12020392] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
7 Demény MA, Virág L. The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions. Cancers (Basel) 2021;13:2057. [PMID: 33923319 DOI: 10.3390/cancers13092057] [Cited by in F6Publishing: 2] [Reference Citation Analysis]